Learn the critical difference between serious and non-serious adverse events in clinical trials-and when each must be reported. Understand the six FDA criteria, avoid common mistakes, and ensure patient safety without overwhelming the system.
A deep dive into imipramine's discovery, FDA approval, clinical impact, and why it still matters in modern psychiatry.
Lower GI bleeding is often caused by diverticula or angiodysplasia, especially in older adults. Learn how doctors diagnose and treat these common but different conditions, and why early intervention matters.
Second and third generic drug manufacturers drive prescription prices down dramatically-often cutting costs by 50% or more. Learn how competition among generics saves billions and what keeps prices high despite more options.
In my recent dive into medical research, I stumbled upon a controversial topic: the potential link between Amlodipine, a common high blood pressure medication, and cancer. Several studies have surfaced suggesting a possible association, but the evidence is inconsistent and not yet fully understood. It's essential to remember that correlation does not imply causation, so while this topic definitely warrants further research, there's no need for panic. If you're currently taking Amlodipine, don't stop or change your medication without first discussing it with your doctor. Stay tuned as I continue to monitor this ongoing discussion.
Secondary patents let pharmaceutical companies extend market exclusivity by patenting minor changes to drugs - not the active ingredient, but how it's delivered, used, or made. These tactics delay generics and keep prices high.